Pricing and reimbursement
AIFA intervenes in the governance of pharmaceutical expenditure by negotiating the price of medicinal products and managing the National Pharmaceutical Formulary (PFN).
In addition, AIFA monitors the appropriateness of use of medicines through the development, management and analysis of registers and consumption data.
It periodically reviews the Notes, which are regulatory tools that define the eligibility for reimbursement of some medicinal products and are updated on the basis of new scientific evidence and the needs of daily medical practice on the national territory.
Every month, the Agency also publishes the updated transparency lists, which are the lists of medicinal products whose patent coverage has expired, with the relative reference prices.
17/03/2017
16/03/2017
14/03/2017
10/03/2017
07/03/2017
27/02/2017
15/02/2017
08/02/2017
06/02/2017
06/02/2017
06/02/2017
31/01/2017
26/01/2017
23/01/2017
16/01/2017
28/12/2016
12/12/2016
09/12/2016
06/10/2016
22/11/2016
22/11/2016
08/11/2016
07/11/2016
31/10/2016
28/10/2016
17/10/2016
11/10/2016
03/10/2016
27/09/2016
27/09/2016
16/09/2016
09/09/2016
31/08/2016
30/08/2016
22/08/2016
20/07/2016
05/07/2016